| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +2.5M | 71.9% | $13.50 | +$33.7M |
| Sells | 4 | -975K | 28.1% | $13.07 | -$12.7M |
| Net | -1 | +1.52M | 43.8% | +$21M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Brian Taylor Slingsby | Director, 10%+ Owner | $113M | -$7.18M | -5.98% | Feb 13, 2025 |
| Srinivas Akkaraju | Director | $76.6M | +$8.1M | +11.8% | Mar 13, 2025 |
| Samsara BioCapital GP, LLC | 10%+ Owner | $76.6M | +$8.1M | +11.8% | Mar 13, 2025 |
| Ra Capital Management, L.P. | Director | $57.8M | +$17.5M | +43.4% | Mar 13, 2025 |
| HBM Healthcare Investments (Cayman) Ltd. | 10%+ Owner | $19.2M | Feb 14, 2023 | ||
| Jon Congleton | Chief Executive Officer, Director | $10.5M | -$2.29M | -17.9% | Apr 11, 2025 |
| Adam Levy | CFO and Secretary | $2.6M | -$1.77M | -40.5% | Apr 11, 2025 |
| David Malcom Rodman | Chief Medical Officer | $1.66M | -$1.51M | -47.7% | Apr 14, 2025 |
| Glenn Sblendorio | Director | Feb 13, 2025 | |||
| Alexander M. Gold | Director | Feb 13, 2025 | |||
| Daphne Karydas | Director | Feb 13, 2025 | |||
| Derek DiRocco | Director | Feb 13, 2025 | |||
| Takeshi Takahashi | Director | Jul 12, 2023 | |||
| Olivier Litzka | Director | May 22, 2024 | |||
| Alexander Asam | Director | Feb 9, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|